Marksans Pharma Ltd. — Capital/Financing Update 2021

Jun 10, 2021

•• Marksans Pharma Ltd.

BSE Limited Corporate Relation Department Phiroze Jeejeeboi Towers, Dalal Street, Mumbai - 400001. Scrip Code: 524404

National Stock Exchange of India Limited Listing Department Exchange Plaza, C-1, Block-G, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051. Symbol: MARKSANS

This is to inform you that the Meeting of the Board of Directors of the Company will be held on Tuesday, 15[th] June, 2021, inter alia, to consider issuance of convertible warrants on preferential basis as per details given below:

==> picture [451 x 135] intentionally omitted <==

----- Start of picture text ----- Sr. Name of proposed Number of Price per warrants Total value ofNo. allottee warrants INR issue INR1 Mr. Mark Saldanha 10,00,000 74.00 (including 7,40,00,000.00(Promoter) premium of Rs.• 73.00)2 OrbiMed Asia IV Mauritius 4,93,24,324 74.00 (including 3,64,99,99,976.00FVCILimited premium of Rs.73.00)Total 5,03,24,324 3,7239,999,76.00----- End of picture text -----

Please note that as per the Insider Trading Code of the Company, the Trading Window for dealing in Company's shares will remain closed for the Company's insiders from the date of this letter until close of 17[th] June, 2021.

Yours faithfully, For Marksans;;Pharma,:k Limited _ .~LWA_ Harshavardhan Panigrahi Company Secretary

Marksans Pharma Ltd.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • E-mail: info@marksanspharma.com www.marksanspharma.com